Raziel Therapeutics is a cutting-edge brand that is revolutionizing fat removal treatments by utilizing the body's natural healing mechanism. With a strong focus on science and backed by prominent investors, Raziel Therapeutics builds upon groundbreaking research conducted at the prestigious Hebrew University in Jerusalem. At Raziel Therapeutics, we are currently conducting multiple clinical studies to address various indications related to fat disorders and aesthetics.

Our goal is to develop innovative therapies that provide effective and long-lasting results. Led by a highly experienced management team, including CEO Alon Bloomenfeld, who has a proven track record in the industry, as well as VP of R&D, Eran Blaugrund, and Clinical Development expert, Racheli Gueta, Raziel Therapeutics brings a wealth of expertise to the table. With an emphasis on scientific advancement and a commitment to improving the lives of patients, Raziel Therapeutics is at the forefront of the fat removal field, pushing boundaries and transforming the way we approach body contouring and other fat-related conditions